Molecular virology of hepatitis C
Hepatitis C virus (HCV) infection is a leading cause of chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma worldwide. Here, we will briefly review current concepts of the molecular virology of hepatitis C. In vitro and in vivo models of HCV replication will be discussed in this context...
Gespeichert in:
Veröffentlicht in: | Praxis (Bern. 1994) 2002-12, Vol.91 (51-52), p.2247-2253 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | ger |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 2253 |
---|---|
container_issue | 51-52 |
container_start_page | 2247 |
container_title | Praxis (Bern. 1994) |
container_volume | 91 |
creator | Moradpour, D Brass, V Gosert, R Wölk, B Blum, H E |
description | Hepatitis C virus (HCV) infection is a leading cause of chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma worldwide. Here, we will briefly review current concepts of the molecular virology of hepatitis C. In vitro and in vivo models of HCV replication will be discussed in this context. Finally, novel antiviral strategies will be outlined that result from an improved understanding of the viral life cycle. |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_72839988</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>72839988</sourcerecordid><originalsourceid>FETCH-LOGICAL-p541-c731dc8a18545e5ead8f3f681f0f31540215c653691127d2f720540c763da3b93</originalsourceid><addsrcrecordid>eNo1j81KxDAYRbNQnHH0FaRu3BXyJfmSdCnFPxhxM_uSyY9GUlOTVpi3d8BxdeByuHDOyBqkhFYDqhW5rPWTUik6hhdkBQyloALW5PY1J2-XZErzE0tO-f3Q5NB8-MnMcY616a_IeTCp-usTN2T3-LDrn9vt29NLf79tJxTQWsXBWW1Ao0CP3jgdeJAaAg0cUFAGaCVy2QEw5VhQjB5XqyR3hu87viF3f7dTyd-Lr_Mwxmp9SubL56UOimnedVofxZuTuOxH74apxNGUw_DfxH8BvnZEew</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72839988</pqid></control><display><type>article</type><title>Molecular virology of hepatitis C</title><source>Hogrefe eContent</source><source>MEDLINE</source><creator>Moradpour, D ; Brass, V ; Gosert, R ; Wölk, B ; Blum, H E</creator><creatorcontrib>Moradpour, D ; Brass, V ; Gosert, R ; Wölk, B ; Blum, H E</creatorcontrib><description>Hepatitis C virus (HCV) infection is a leading cause of chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma worldwide. Here, we will briefly review current concepts of the molecular virology of hepatitis C. In vitro and in vivo models of HCV replication will be discussed in this context. Finally, novel antiviral strategies will be outlined that result from an improved understanding of the viral life cycle.</description><identifier>ISSN: 1661-8157</identifier><identifier>PMID: 12564041</identifier><language>ger</language><publisher>Switzerland</publisher><subject>Animals ; Antiviral Agents - therapeutic use ; Cells, Cultured ; Disease Models, Animal ; Enzyme Inhibitors - therapeutic use ; Forecasting ; Genes, Viral ; Genetic Therapy ; Hepacivirus - enzymology ; Hepacivirus - genetics ; Hepacivirus - physiology ; Hepatitis C - complications ; Hepatitis C - drug therapy ; Hepatitis C - therapy ; Hepatitis C - virology ; Hepatocytes - virology ; Humans ; Mice ; Mice, Transgenic ; Pan troglodytes ; Polyproteins - genetics ; Polyproteins - metabolism ; Protease Inhibitors - therapeutic use ; Protein Biosynthesis ; Replicon - genetics ; RNA, Viral - genetics ; Transcription, Genetic ; Tumor Cells, Cultured ; Tupaia ; Viral Proteins - genetics ; Viral Proteins - metabolism ; Virus Replication</subject><ispartof>Praxis (Bern. 1994), 2002-12, Vol.91 (51-52), p.2247-2253</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12564041$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Moradpour, D</creatorcontrib><creatorcontrib>Brass, V</creatorcontrib><creatorcontrib>Gosert, R</creatorcontrib><creatorcontrib>Wölk, B</creatorcontrib><creatorcontrib>Blum, H E</creatorcontrib><title>Molecular virology of hepatitis C</title><title>Praxis (Bern. 1994)</title><addtitle>Praxis (Bern 1994)</addtitle><description>Hepatitis C virus (HCV) infection is a leading cause of chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma worldwide. Here, we will briefly review current concepts of the molecular virology of hepatitis C. In vitro and in vivo models of HCV replication will be discussed in this context. Finally, novel antiviral strategies will be outlined that result from an improved understanding of the viral life cycle.</description><subject>Animals</subject><subject>Antiviral Agents - therapeutic use</subject><subject>Cells, Cultured</subject><subject>Disease Models, Animal</subject><subject>Enzyme Inhibitors - therapeutic use</subject><subject>Forecasting</subject><subject>Genes, Viral</subject><subject>Genetic Therapy</subject><subject>Hepacivirus - enzymology</subject><subject>Hepacivirus - genetics</subject><subject>Hepacivirus - physiology</subject><subject>Hepatitis C - complications</subject><subject>Hepatitis C - drug therapy</subject><subject>Hepatitis C - therapy</subject><subject>Hepatitis C - virology</subject><subject>Hepatocytes - virology</subject><subject>Humans</subject><subject>Mice</subject><subject>Mice, Transgenic</subject><subject>Pan troglodytes</subject><subject>Polyproteins - genetics</subject><subject>Polyproteins - metabolism</subject><subject>Protease Inhibitors - therapeutic use</subject><subject>Protein Biosynthesis</subject><subject>Replicon - genetics</subject><subject>RNA, Viral - genetics</subject><subject>Transcription, Genetic</subject><subject>Tumor Cells, Cultured</subject><subject>Tupaia</subject><subject>Viral Proteins - genetics</subject><subject>Viral Proteins - metabolism</subject><subject>Virus Replication</subject><issn>1661-8157</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1j81KxDAYRbNQnHH0FaRu3BXyJfmSdCnFPxhxM_uSyY9GUlOTVpi3d8BxdeByuHDOyBqkhFYDqhW5rPWTUik6hhdkBQyloALW5PY1J2-XZErzE0tO-f3Q5NB8-MnMcY616a_IeTCp-usTN2T3-LDrn9vt29NLf79tJxTQWsXBWW1Ao0CP3jgdeJAaAg0cUFAGaCVy2QEw5VhQjB5XqyR3hu87viF3f7dTyd-Lr_Mwxmp9SubL56UOimnedVofxZuTuOxH74apxNGUw_DfxH8BvnZEew</recordid><startdate>20021218</startdate><enddate>20021218</enddate><creator>Moradpour, D</creator><creator>Brass, V</creator><creator>Gosert, R</creator><creator>Wölk, B</creator><creator>Blum, H E</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>20021218</creationdate><title>Molecular virology of hepatitis C</title><author>Moradpour, D ; Brass, V ; Gosert, R ; Wölk, B ; Blum, H E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p541-c731dc8a18545e5ead8f3f681f0f31540215c653691127d2f720540c763da3b93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>ger</language><creationdate>2002</creationdate><topic>Animals</topic><topic>Antiviral Agents - therapeutic use</topic><topic>Cells, Cultured</topic><topic>Disease Models, Animal</topic><topic>Enzyme Inhibitors - therapeutic use</topic><topic>Forecasting</topic><topic>Genes, Viral</topic><topic>Genetic Therapy</topic><topic>Hepacivirus - enzymology</topic><topic>Hepacivirus - genetics</topic><topic>Hepacivirus - physiology</topic><topic>Hepatitis C - complications</topic><topic>Hepatitis C - drug therapy</topic><topic>Hepatitis C - therapy</topic><topic>Hepatitis C - virology</topic><topic>Hepatocytes - virology</topic><topic>Humans</topic><topic>Mice</topic><topic>Mice, Transgenic</topic><topic>Pan troglodytes</topic><topic>Polyproteins - genetics</topic><topic>Polyproteins - metabolism</topic><topic>Protease Inhibitors - therapeutic use</topic><topic>Protein Biosynthesis</topic><topic>Replicon - genetics</topic><topic>RNA, Viral - genetics</topic><topic>Transcription, Genetic</topic><topic>Tumor Cells, Cultured</topic><topic>Tupaia</topic><topic>Viral Proteins - genetics</topic><topic>Viral Proteins - metabolism</topic><topic>Virus Replication</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Moradpour, D</creatorcontrib><creatorcontrib>Brass, V</creatorcontrib><creatorcontrib>Gosert, R</creatorcontrib><creatorcontrib>Wölk, B</creatorcontrib><creatorcontrib>Blum, H E</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Praxis (Bern. 1994)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Moradpour, D</au><au>Brass, V</au><au>Gosert, R</au><au>Wölk, B</au><au>Blum, H E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Molecular virology of hepatitis C</atitle><jtitle>Praxis (Bern. 1994)</jtitle><addtitle>Praxis (Bern 1994)</addtitle><date>2002-12-18</date><risdate>2002</risdate><volume>91</volume><issue>51-52</issue><spage>2247</spage><epage>2253</epage><pages>2247-2253</pages><issn>1661-8157</issn><abstract>Hepatitis C virus (HCV) infection is a leading cause of chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma worldwide. Here, we will briefly review current concepts of the molecular virology of hepatitis C. In vitro and in vivo models of HCV replication will be discussed in this context. Finally, novel antiviral strategies will be outlined that result from an improved understanding of the viral life cycle.</abstract><cop>Switzerland</cop><pmid>12564041</pmid><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1661-8157 |
ispartof | Praxis (Bern. 1994), 2002-12, Vol.91 (51-52), p.2247-2253 |
issn | 1661-8157 |
language | ger |
recordid | cdi_proquest_miscellaneous_72839988 |
source | Hogrefe eContent; MEDLINE |
subjects | Animals Antiviral Agents - therapeutic use Cells, Cultured Disease Models, Animal Enzyme Inhibitors - therapeutic use Forecasting Genes, Viral Genetic Therapy Hepacivirus - enzymology Hepacivirus - genetics Hepacivirus - physiology Hepatitis C - complications Hepatitis C - drug therapy Hepatitis C - therapy Hepatitis C - virology Hepatocytes - virology Humans Mice Mice, Transgenic Pan troglodytes Polyproteins - genetics Polyproteins - metabolism Protease Inhibitors - therapeutic use Protein Biosynthesis Replicon - genetics RNA, Viral - genetics Transcription, Genetic Tumor Cells, Cultured Tupaia Viral Proteins - genetics Viral Proteins - metabolism Virus Replication |
title | Molecular virology of hepatitis C |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T10%3A23%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Molecular%20virology%20of%20hepatitis%20C&rft.jtitle=Praxis%20(Bern.%201994)&rft.au=Moradpour,%20D&rft.date=2002-12-18&rft.volume=91&rft.issue=51-52&rft.spage=2247&rft.epage=2253&rft.pages=2247-2253&rft.issn=1661-8157&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E72839988%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72839988&rft_id=info:pmid/12564041&rfr_iscdi=true |